Genmab | 営業経費



Operating Expenses 変化する 日付
Agios Pharmaceuticals USD 139.51M 24.16M 2025-06
Almirall EUR 517.43M 265.53M 2025-06
Amarin USD 58.77M 56.06M 2025-03
Amgen USD 6.52B 337M 2025-06
argenx SE USD 744.12M 92.38M 2025-06
AstraZeneca USD 10.95B 1.04B 2025-06
Bayer EUR 10.73B 688M 2025-06
BioMarin Pharmaceutical USD 548.52M 27.27M 2025-06
Demant DKK 9.39B 392M 2025-06
Exelixis USD 354.68M 13.9M 2025-07
Fresenius Medical Care EUR 4.36B 189M 2025-06
Galapagos EUR 122.32M 111.37M 2025-06
Genmab DKK 565M 38M 2025-06
GlaxoSmithKline GBP 5.96B 663M 2025-06
GN Store Nord DKK 3.7B 72M 2025-06
GRIFOLS EUR 1.54B 24.64M 2025-06
Hikma Pharmaceutical USD 1.31B 63M 2024-12
Insmed USD 361.29M 20.33M 2025-06
Lonza CHF 3.09B 564M 2024-12
Merck EUR 4.22B 49M 2025-06
Novartis USD 9.97B 1.02B 2025-06
Regeneron Pharmaceuticals USD 2.6B 159.1M 2025-06
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 9.02B 702M 2025-06
UCB EUR 2.36B 108M 2024-12


Genmab 営業経費 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Sep 2025.